Future LRMN Events
LRMN & The Cure Parkinson's Trust - 6.00 pm Thursday 23rd February 2012 at UCL
“Cell therapies or growth factors: which carries the greater future potential for treating Parkinson's disease?"
The February 2012 meeting of the London Regenerative Medicine Network, in partnership with The Cure Parkinson's Trust, will focus on cell therapy for Parkinson's disease with three world experts. The Cure Parkinson's Trust has one bold aim - to cure Parkinson's disease by funding innovative projects and inspirational scientists with the aim of building momentum towards a cure. Founded by patients, the Trust is passionate about involving patients in this vision.
This meeting is FREE OF CHARGE to attend due to the very kind support from The Cure Parkinson's Trust. It will take place on Thursday 23rd February 2012 at 6.00 pm in the Garden Room and Gustave Tuck Lecture Theatre, Wilkins Building, University College London – A short walk from Euston Square, Goodge Street and Warren Street Tube Stations and Euston Station.
Registration: 6.00 - 6.30 pm
Presentations: 6.30 - 8.30 pm
Networking Reception 8.30 - 10.30 pm
********
AGENDA:
18.00 - Registration over tea and coffee in the Garden Room (Wilkins Building, UCL)
18.25 - Walk up to the Gustave Tuck Lecture Theatre (Wilkins Building, UCL)
18.30 - Welcome - Dr. Richard Wyse, Director of Research and Development, The Cure Parkinson's Trust (London, UK)
18.35 - Opening remarks from the chairman - Prof. Roger Barker, University of Cambridge and Addenbrooke’s Hospital (Cambridge, UK), and co-ordinator of the FP7 TRANSEURO project
18.40 - "Dopaminergic neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease" - Dr. Sonja Kriks, Memorial Sloan-Kettering Cancer Center (New York, NY, US)
19.05 - Q & A
19:10 - "Restoring brains with Parkinson’s disease: the next few years and beyond" - Dr. Alan Whone, Department of Neurology and the Burden Institute, Frenchay Hospital (Bristol, UK)
19.35 - Q & A
19.40 - "Nurr1: A novel therapeutic target in Parkinson’s Disease AND Cell transplantation in Parkinson's disease: an update" - Prof. Anders Bjorklund, Wallenberg Neuroscience Center, Lund University (Lund, Sweden)
20.20 - Q + A
20.25 - Closing remarks - Prof. Chris Mason - Advanced Centre for Biochemical Engineering, UCL
20.30 - 22.30 - LRMN Reception - Network whilst enjoying a glass of wine or two in the Garden Room (Wilkins Building, UCL)
********
SPONSORS + PARTNERS
EVENT SPONSORS: This LRMN meeting is FREE TO ATTEND through the support of The Cure Parkinson's Trust
PROMOTIONAL SUPPORT: 'Regenerative Medicine'
*******
PLEASE NOTE THAT DUE TO LECTURE THEATRE SEATING CAPACITY, IF YOU WISH TO ATTEND THIS EVENT YOU MUST EMAIL office@lrmn.com, OTHERWISE UNFORTUNATELY YOU WILL NOT BE ABLE TO GAIN ADMISSION. Seat allocation is on a first come, first served basis. Please only register if you can definitely make the meeting. If you have to cancel later do please let us know.
The LRMN Team very much look forward to welcoming you at 6.00 pm on Thursday 23rd February 2012 for an event that will focus on – "Cell therapies or growth factors: which carries the greater future potential for treating Parkinson's disease?". This is the second of our popular single theme events held in partnership with The Cure Parkinson's Trust and aims to update the audience on developments within the entire spectrum of advanced approaches aimed ultimately at curing Parkinson's disease.